Phase 1 Alzheimer Dementia Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Innate Immunity Stimulation Via TLR9 in Early AD
Mild Cognitive ImpairmentAlzheimer Dementia
NYU Langone Health18 enrolled1 locationNCT05606341
Recruiting
Phase 1
A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
Alzheimer Dementia (AD)
Augusta University12 enrolled1 locationNCT07218081
Recruiting
Phase 1
Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)
National University Hospital, Singapore48 enrolled1 locationNCT07210528